Jing Bao
National Institutes of Health, USA
Title: Advantages and challenges conducting clinical trials in China
Biography
Biography: Jing Bao
Abstract
As the rising economic superpower in the world, China is now striving to be at the forefront of clinical research and drug development. There are many advantages to conducting clinical trials in China including large patient populations, a large and growing network of hospitals qualified to conduct high standard clinical trials, skilled clinical trial and laboratory professionals and project leaders, strong support from the government for international partnerships, improved regulatory environment for clinical trials and new drug approval, and strong enthusiasm for international collaborations. However, several challenges remain, such as large migrant populations, language and cultural differences, and the uncontrolled use of traditional Chinese medicine. Timely importation of study agents is one other significant challenge. Quality control is the key to ensure clinical research projects meet the highest standards. The recent changing drug regulatory landscapes have also brought attention and galvanized international companies that intend to conduct drug trials in China.
This workshop, using the real examples, will present and discuss the advantages and challenges of conducting clinical trials in China. The pitfalls to avoid and possible solutions to conducting high quality clinical trials in China will be emphasized.